BREAKING NEWS: FDA approves booster shot from Moderna and Johnson & Johnson and says COVID-19 vaccines can be mixed
- The FDA on Wednesday approved booster shots for the Moderna and Johnson & Johnson COVID-19 vaccines
- Officials will also allow Americans to get a booster shot different from the vaccine they received
The U.S. Food and Drug Administration (FDA) on Wednesday approved booster shots for the Moderna and Johnson & Johnson COVID-19 vaccines.
The additional J&J doses are for all adults 18 years and older, while Modena’s third injection is only for people 65 and older or at high risk due to underlying conditions or their job.
It comes a week after the FDA recommended an advisory committee that officials approve the two companies’ booster doses.
The federal health agency will also allow fully vaccinated Americans to “mix and match” Covid vaccines and booster shots.
This means that people can get a booster made by a different company than the company that made the vaccine they were initially given.
The FDA has authorized booster shots for the Moderna and Johnson & Johnson COVID-19 vaccines. Pictured: Dr. Richard Schwartz receives a Pfizer Covid vaccine booster at the Teaching Center LIJ Medical Center in New York, Oct. 6
“Today’s actions demonstrate our commitment to public health by proactively fighting the COVID-19 pandemic,” Acting FDA Commissioner Dr Janet Woodcock said in a statement.
“As the pandemic continues to hit the country, science has shown that vaccination is still the safest and most effective way to prevent COVID-19, including the most serious consequences of the disease, such as hospitalization and death.
‘The available data point to declining immunity in some fully vaccinated populations. The availability of these authorized boosters is important for continued protection against COVID-19 disease.”
J&J’s approval comes after the company published data in September on the effectiveness of a second dose given 56 days after the first in adults aged 18 years and older.
The results showed that a booster injection was 94 percent effective against symptomatic COVID-19 in the US and 100 percent effective against critical illness at least 14 days after vaccination.
This is comparable to 70 percent protection with a single dose.
There was only one case of COVID-19 in the vaccine group and 14 in the placebo group.
J&J said that a booster given two months after the first dose increased antibody levels between fourfold and sixfold.
When administered six months after the first dose, antibody levels shot nine-fold after one week and twelve-fold after four weeks.
This is a latest news item and will be updated.